Drugs that contain Diroximel Fumarate

1. Drug name - VUMERITY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US10080733 BIOGEN INC Prodrugs of fumarates and their use in treating various diseases
Sep, 2033

(10 years from now)

US8669281 BIOGEN INC Prodrugs of fumarates and their use in treating various diseases
Sep, 2033

(10 years from now)

CN107501110A BIOGEN INC Ester Prodrugs And Their Use In The Treatment Of Various Diseases In The Application
Mar, 2034

(11 years from now)

CN105452213A BIOGEN INC Fumarate Prodrug And Application In Treating Multiple Disease
Mar, 2034

(11 years from now)

CN107501110B BIOGEN INC Fumaric Acid Ester Prodrugs And The Use Thereof In The Treatment Of Various Diseases
Mar, 2034

(11 years from now)

CN105452213B BIOGEN INC Fumaric Acid Ester Prodrugs And Their Use In The Treatment Of Various Diseases In The Application
Mar, 2034

(11 years from now)

EP2970101A4 BIOGEN INC Prodrugs Of Fumarates And Their Use In Treating Various Deseases
Mar, 2034

(11 years from now)

EP2970101B1 BIOGEN INC Prodrugs Of Fumarates And Their Use In Treating Various Deseases
Mar, 2034

(11 years from now)

EP2970101A1 BIOGEN INC Prodrugs Of Fumarates And Their Use In Treating Various Deseases
Mar, 2034

(11 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9090558 BIOGEN INC Prodrugs of fumarates and their use in treating various diseases Sep, 2033

(10 years from now)

Treatment: Method of treating multiple sclerosis

Dosage: CAPSULE, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
231MG CAPSULE, DELAYED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.